Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System

Background: The use of real-time continuous glucose monitoring (rtCGM) systems has proved to positively impact the management of type 1 diabetes with the potential to lower HbA1c, reduce frequency and time spent in hypoglycemia, and lower glycemic variability. Nevertheless, the acceptance of rtCGM r...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Technol Ther
Hlavní autoři: Deiss, Dorothee, Szadkowska, Agnieszka, Gordon, Debbie, Mallipedhi, Akhila, Schütz-Fuhrmann, Ingrid, Aguilera, Eva, Ringsell, Corina, De Block, Christophe, Irace, Concetta
Médium: Artigo
Jazyk:Inglês
Vydáno: Mary Ann Liebert, Inc., publishers 2019
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6532544/
https://ncbi.nlm.nih.gov/pubmed/31021180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2018.0397
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky